Global structural biology Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global structural biology Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Structural biology is a science that quantitatively elucidates life phenomena during the development of modern biology. Structural biology mainly uses physical means, using X-ray crystallography, nuclear magnetic resonance spectroscopy, electron microscopy and other physical techniques to study the function and structure of biological macromolecules to elucidate the mechanisms in the interactions of these macromolecules.

Market Overview:

The latest research study on the global structural biology market finds that the global structural biology market reached a value of USD 728.0 million in 2023. It’s expected that the market will achieve USD 1658.3 million by 2029, exhibiting a CAGR of 14.71% during the forecast period.

Structural biology is the frontier and mainstream of life sciences. Every frontier breakthrough in molecular biology is closely related to structural biology. Structural biology has penetrated into various related fields of biology, and the research scope of structural biology has covered much of the world. For most important life activities, the elucidation of the molecular mechanisms of life processes has reached unprecedented depth and breadth. Structural biology is increasingly relevant to human health and disease. Since structural biology can explain the conformation and interaction of biological macromolecules, and all life activities are achieved through the interaction of various biological macromolecules; therefore, this is a very important issue for biologists. Attractive areas. Determination of the three-dimensional structure of proteins and their complexes is one of the most important scientific foundations for biological research. In pharmaceutical research and development, protein crystallography is also widely used in the design of new drugs based on structure.

At present, there are three main methods to determine the three-dimensional structure of proteins: X-ray crystallography, nuclear magnetic resonance technology (NMR) and cryo-electron microscopy three-dimensional reconstruction technology. These research methods have their advantages and disadvantages, and different research objects require different methods. X-ray crystallography is currently the highest resolution structure determination method, but it must first obtain protein crystals. It is difficult to obtain crystals for proteins with large molecular weights and membrane proteins, which is its limitation. NMR spectroscopy is more suitable for studying proteins with small molecular weight (usually less than 20kDa) and information about protein interaction sites, while cryo-EM is more suitable for studying the structure of very large molecular weight protein complexes (usually much larger than 100kDa) and even subcellular organelles; therefore, it is often There is a need to complement each other by combining different approaches.

Strong support from national policies promotes industry development

In recent years, the Chinese government has continuously increased its support for pharmaceutical research and development. In February 2020, the State Council issued the Opinions on Deepening the Reform of the Medical Security System, requiring the acceptance and review of the quality and efficacy consistency evaluation of generic drugs, and supporting high-quality generic drugs by improving medical insurance payment standards and drug bidding and procurement mechanisms. Research, development and use, promote the substitution of generic drugs; enhance the accessibility of pharmaceutical services, and coordinately promote the supply-side reform of pharmaceutical services. The introduction of encouraging policies not only encourages the pharmaceutical R&D industry to actively innovate to meet the needs of various fields, but also creates a good policy environment for the development of the pharmaceutical R&D industry, effectively promotes the stable and rapid development of the pharmaceutical R&D industry, thereby driving the growth of demand for structural biology services in my country.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects

Company Overview:

Charles River
With 100 sites worldwide, Charles River is strategically positioned to coordinate global resources and apply a multidisciplinary perspective to solve a product's unique challenges. Charles River's focus on timeliness and accuracy at every development stage means customers can rely on reliable, repeatable results. Service areas include basic research, discovery, safety and efficacy, clinical support and manufacturing. Employees: Over 20,000 worldwide

Shanghai WuXi AppTec New Drug Development Co., Ltd.

Combining WuXi AppTec's chemistry, biology, oncology and immunology technology platforms, WuXi AppTec's research service platform provides one-stop drug discovery and research services to global customers. Services cover medicinal chemistry, synthetic chemistry, chemical analysis, DNA-encoded compound libraries, immuno-oncology, in vivo tumor models, CRISPR, molecular and cellular level drug efficacy testing, high-throughput screening (HTS), early safety assessment, various Large and small animal pharmacodynamic models (cardiovascular diseases, respiratory diseases, diabetes and obesity, fatty liver, neurodegeneration and cognitive impairment, pain, sleep, psychiatric diseases, viral and bacterial infection models), structural biology, Immunology and clinical biomarker testing services, etc.

Segmentation Overview:

Among different product types, Protein purification and crystallization screening segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Drug research and development segment occupied the biggest share from 2018 to 2022.

Key Companies in the global structural biology market covered in Chapter 3:

Helix BioStructures
Charles River
Pharmaron (Beijing) New Drug Technology Co., LTD
Crown organism
NanoImaging
CrystalsFirst
Synbio Technologies
Proteros
NYSBC
Medici
Creative Biostructure
Via Biotechnology Holding Group
Wuxi Biao Bioscience Co., LTD
Selvita
NovAliX
Jubilant Biosys
Shanghai Wuxi Apptec New Drug Development Co., LTD

In Chapter 4 and Chapter 14.2, on the basis of types, the structural biology market from 2019 to 2030 is primarily split into:

Protein expression
Protein purification and crystallization screening
Crystallographic structure analysis
Analysis and quality control
other

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the structural biology market from 2019 to 2030 covers:

Scientific research
Clinical research
Drug research and development

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)